After scoring FDA clearance, Prana Surgical CEO targets strategic rollout for surgical device
perigon
Last updated: April 14, 2026
A Houston-based startup has achieved a significant milestone with FDA clearance for its innovative surgical device. This clearance was facilitated by substantial backing from both the Cancer Prevention and Research Institute of Texas (CPRIT) and the global healthcare giant Johnson & Johnson.
- The startup's surgical device has officially received clearance from the U.S. Food and Drug Administration (FDA). This groundbreaking development marks a crucial step for the company in bringing its technology to the medical field. Significant financial support was provided by the Cancer Prevention and Research Institute of Texas (CPRIT), an organization dedicated to advancing cancer research and prevention. Additionally, Johnson & Johnson, a leading multinational medical device, pharmaceutical, and consumer packaged goods company, has also invested in the startup, signaling confidence in its potential. The founder of the company shared details about this achievement and the device's implications with the Houston Business Journal, highlighting the collaborative effort and the product's promise for surgical procedures. The specific nature of the surgical device and its intended applications were central to the discussions.
